Jinling Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinling Pharmaceutical Company Limited with three other
companies in this sector in CHINA :
Jiang Zhong Pharmaceutical Co Ltd
sales of 2.45 billion Chinese Renmimbi [US$358.87 million]
of which 99%
was Medical Industry),
Guangdong Zhongsheng Pharmaceutical Co Ltd
(2.53 billion Chinese Renmimbi [US$370.97 million]
of which 90%
was Medicine Manufacture), and
Autobio Diagnostics Co Ltd
(2.68 billion Chinese Renmimbi [US$392.64 million]
of which 97%
was In vitro diagnosis).
Jinling Pharmaceutical Company Limited reported sales of 2.53 billion Chinese Renmimbi (US$371.47 million)
December of 2019.
decrease of 12.6%
versus 2018, when the company's sales were 2.90 billion Chinese Renmimbi.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Jinling Pharmaceutical Company Limited had sales
of 2.77 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 66.0% decline
in Other, from 76.39 million Chinese Renmimbi to 25.98 million Chinese Renmimbi.
There were also decreases in sales in
Medicine Manufacturing (down 20.7% to 1.37 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Medical Service (up 4.0% to 1.14 billion Chinese Renmimbi)